2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
生物活性
Description
In Vivo
In Vitro
化合物的使用
Kinase Assay
Cell Assay
Animal Administration
参考文献
Elagolix is a Gonadotropin-Releasing Hormone (GnRH) Antagonist. Elagolix inhibits gonadatropin releasing hormone (GnRH) receptors in the pituitary gland and ultimately reduces circulating sex hormone levels. To date, elagolix has been studied in over 20 clinical trials totaling more than 1,000 subjects. A Phase 2a trial of elagolix For the treatment of uterine fibroids is also ongoing. Endometriosis can be a debilitating disease that affects millions of women around the world and the exploration of new treatments could offer other options For women with this diseaseFor the detailed information of Elagolix, the solubility of Elagolix in water, the solubility of Elagolix in DMSO, the solubility of Elagolix in PBS buffer, the animal experiment (test) of Elagolix, the cell expriment (test) of Elagolix, the in vivo, in vitro and clinical trial test of Elagolix, the EC50, IC50,and Affinity of Elagolix, Please contact DC Chemicals.
